KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Non-Current Deffered Revenue (2016 - 2025)

Resmed (RMD) has disclosed Non-Current Deffered Revenue for 16 consecutive years, with $159.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deffered Revenue rose 9.06% year-over-year to $159.8 million, compared with a TTM value of $159.8 million through Dec 2025, up 9.06%, and an annual FY2025 reading of $156.8 million, up 14.17% over the prior year.
  • Non-Current Deffered Revenue was $159.8 million for Q4 2025 at Resmed, roughly flat from $159.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $159.8 million in Q4 2025 and bottomed at $86.9 million in Q1 2021.
  • Average Non-Current Deffered Revenue over 5 years is $121.0 million, with a median of $120.3 million recorded in 2023.
  • The sharpest move saw Non-Current Deffered Revenue grew 2.7% in 2021, then grew 24.86% in 2023.
  • Year by year, Non-Current Deffered Revenue stood at $94.4 million in 2021, then grew by 8.87% to $102.8 million in 2022, then increased by 23.94% to $127.4 million in 2023, then grew by 14.99% to $146.5 million in 2024, then rose by 9.06% to $159.8 million in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for RMD at $159.8 million in Q4 2025, $159.4 million in Q3 2025, and $156.8 million in Q2 2025.